FDA: Alzheimer's, Amyvid (florbetapir)

From MedPage Today:

FDA Puts Early Alzheimer's Test on Hold
By Peggy Peck, Executive Editor
MedPage Today
Published: March 18, 2011

[snip]

"The FDA will not approve the novel contrast agent, florbetapir -- widely touted as a breakthrough for early diagnosis of Alzheimer's disease -- until manufacturer Eli Lilly puts a training program in place, the company announced."

[snip]

Read the article.

Alzheimer's: The Current Pipeline

FierceBiotechResearch has an article which presents a very brief overview of the current Alzheimer's disease drug pipeline:

It is available at the link below:

Making sense of the Alzheimer's drug pipeline
FierceBiotechResearch
March 15, 2011 — 7:53am ET
By Howard Lovy

Read the full article

If this area is new to you, the article will give you the names of some candidates that you can learn about as part of your introduction. There are many other overview articles and public resources available to you concerning clinical-trials research. You might wish, for example, to cross reference the names cited here with the ClinicalTrials.gov database.

If you are a Brain Awareness Week visitor, you can visit the Alzheimer's Association or other national organizations in your country to learn more about Alzheimer's disease and dementia.

Wonderful Video About Neuronal Connections

Untangling the brain
by Nature Video
09 March 2011

Watch the YouTube video

Handedness

From The New York Times:

On the Left Hand, There Are No Easy Answers
By PERRI KLASS, M.D.
The New York Times
Published: March 6, 2011

"The riddle of why about 10 percent of people are born with the left-dominant variety of this essentially human asymmetry remains."

Read the article